Heart Disease News and Research

Latest Heart Disease News and Research

BSX receives CE Mark approval for TAXUS Element Paclitaxel-Eluting Coronary Stent System

Boston Scientific Corporation today announced it has received CE Mark approval for its TAXUS Element Paclitaxel-Eluting Coronary Stent System, the Company's third-generation drug-eluting stent technology. This approval includes a specific indication for the treatment of diabetic patients.

13 May 2010

Mayo Clinic Women's HealthSource offers information about abdominal aortic aneurysms

Abdominal aortic aneurysms have been considered mainly a man's problem. Men, more often than women, develop a weakened and bulging area in the aorta, the body's largest artery, which poses a risk of rupture. But according to the May issue of Mayo Clinic Women's HealthSource, women aren't risk free.

13 May 2010

FDA approves St. Jude Medical's Unify CRT-D and Fortify ICD devices

St. Jude Medical, Inc., a global medical device company, today announced U.S. Food and Drug Administration (FDA) approval and first U.S. implants of its Unify™ cardiac resynchronization therapy defibrillator (CRT-D) and Fortify™ implantable cardioverter defibrillator (ICD). The new devices feature advanced battery technology and circuitry that allow for the smallest device footprint in the industry and rapid charge times, without any compromise in device longevity or power.

13 May 2010

Pfizer to acquire terguride from Ergonex Pharma GmbH for treatment of PAH

Pfizer Inc. and Ergonex Pharma GmbH announced today that they have entered into an agreement under which Pfizer will acquire terguride, which is in development as a potential treatment for Pulmonary Arterial Hypertension.

13 May 2010

Boston Scientific receives CE Mark approval for TAXUS Element Paclitaxel-Eluting Coronary Stent System

Angiotech Pharmaceuticals, Inc. today announced that its corporate partner, Boston Scientific Corporation, has received CE Mark approval for its TAXUS(R) Element(TM) Paclitaxel-Eluting Coronary Stent System, Boston Scientific's third-generation drug-eluting stent (DES) technology.

13 May 2010

FDA approves Evia pacemaker for distribution in the U.S.

BIOTRONIK today announced that the U.S. Food and Drug Administration has cleared the Evia pacemaker for distribution in the U.S., giving physicians and patients access to a unique Bradycardia system designed and manufactured with BIOTRONIK's unparalleled legacy of quality.

13 May 2010

Nurses give evidence of the horrifying day in Dr. Jayant Patel’s surgery

The trial of Dr. Jayant Patel continues. In recent evidence at the court one of the operating theatre nurses revealed under oath to the Brisbane Supreme Court how staff had tried to deter former Bundaberg-based surgeon Jayant Patel from transferring an unstable patient from the theatre to ICU, where he died. There was earlier evidence that the man was bleeding uncontrollably and also allegations that Patel urged junior doctors not to tell anyone what happened.

12 May 2010

More for mental health and first nurse led clinic

Tuesday’s budget saw the Australian government allocate $7.4 billion for health. Many critics have brought to notice that only $200 million has gone towards mental health. The Rudd government has denied such accusations.

12 May 2010

GTC Biotherapeutics reports lower total net loss of $7.7M for first-quarter 2010

GTC Biotherapeutics, Inc. today reported its financial results for the first fiscal quarter ended April 4, 2010. The total net loss for the first quarter was $7.7 million, or $0.26 per share, compared to $10.4 million, or $0.99 per share, for the first quarter of 2009.

12 May 2010

Carrot Medical, MAVIG execute global marketing and sales channel partnership agreement

Carrot Medical, a leading designer of integrated medical imaging display systems, and MAVIG GmbH, the leading manufacturer of medical imaging monitor suspension systems, announced today the execution of a global marketing and sales channel partnership agreement. This partnership provides a semi-exclusive contract for the sale of all products through MAVIG's global sales channel while offering MAVIG access to the next generation of integrated medical imaging display technology.

12 May 2010

Clinical Data expands PGxHealth's FAMILION tests to include two new tests to diagnose heart diseases

Clinical Data, Inc., announced today that its PGxHealth division is expanding its FAMILION family of genetic tests to include two new tests to diagnose heart diseases. With the launch of a test for Conduction Disease associated with Dilated Cardiomyopathy and a test for Short QT Syndrome, PGxHealth continues to lead the industry with the most comprehensive menu of genetic tests to diagnose or confirm familial heart diseases.

12 May 2010

Spectranetics to demonstrate new Laser Lead Extraction Simulation system at Heart Rhythm 2010

Spectranetics Corporation today announced it will showcase a new advanced Laser Lead Extraction Simulation system at the Heart Rhythm Society's (HRS) 31st Annual Scientific Sessions, Heart Rhythm 2010. The new simulation system is intended to augment traditional procedural training for physicians on laser-assisted lead extraction procedures by permitting hands-on practice with extraction tools and techniques in multiple case scenarios in a virtual operating environment.

12 May 2010

Merck hosts R&D and Business Briefing

Merck & Co., Inc. today hosted its first R&D and Business Briefing since the completion of the Merck and Schering-Plough merger. The event included a comprehensive review of the company's late-stage pipeline, as well as the company's commercial strategy and progress made in the integration of Merck's worldwide operations.

12 May 2010

Sanford-Burnham Scientific Symposium provides wealth of information on microRNAs, RNAi

Investigators from around the country came to Sanford-Burnham Medical Research Institute (Sanford-Burnham) on Friday, May 7, to share their knowledge of the burgeoning young field of microRNAs. These small non-coding nucleic acids turn off proteins and have been implicated in viral infection, cancer, cardiovascular disease, HIV and numerous other conditions.

12 May 2010

Drug-releasing stents do not result in fewer deaths or subsequent heart attacks after angioplasty

Drug-releasing stents are more effective than bare metal stents at keeping a blocked artery open after angioplasty, but the difference does not result in fewer deaths or subsequent heart attacks after the procedure, according to a review of recent studies.

12 May 2010

Genetic tests represent future of cancer care for women

Important progress is being made in women's health through the use of genetic tests, particularly those that help women detect and treat cancer.

12 May 2010

Wheat aleurone contains high levels of potentially healthpromoting compounds

Wheat aleurone is a novel wheat grain fraction with high levels of potentially healthpromoting compounds. New clinical trials with ready-to-eat cereals and bread containing wheat aleurone have been performed, and showed increased blood concentrations of tentatively beneficial compounds such as betaine, and decreased homocysteine and LDL-cholesterol which are both associated with heart disease risk.

12 May 2010

Mutation causing light chain amyloidosis identified

Light chain amyloidosis, a deadly protein misfolding disease, is caused by multiple mutations in cells that are intended to protect the body. Instead, the mutations send misfolded bundles of proteins through the bloodstream, potentially destroying the heart, kidneys, liver or other organs. Mayo Clinic researchers have identified one of these mutations and have shown that the molecule's shifting position is as important as its unique shape. The findings appear in the current issue of the journal Structure.

12 May 2010

Gamma Knife stereotactic radiosurgery safe for treating children with arteriovenous malformations: Study

A new Mayo Clinic study has found that Gamma Knife™ stereotactic radiosurgery is a safe and effective option for selected children with arteriovenous malformations. This study was presented at the American Association of Neurological Surgeons Annual Meeting in Philadelphia last week.

12 May 2010

Periodontal disease treatment reduces blood sugar levels in Type 2 diabetes patients

A study to be published in the latest issue of The Cochrane Library and led by researchers at the University of Edinburgh and supported by colleagues at the Peninsula Dental School, the University of Ottawa and UCL Eastman Dental Institute, suggests that the treatment of serious gum (periodontal) disease in diabetics with Type 2 diabetes may lower their blood sugar levels.

12 May 2010

Heart Disease News and Research

Latest Heart Disease News and Research

BSX receives CE Mark approval for TAXUS Element Paclitaxel-Eluting Coronary Stent System

Mayo Clinic Women's HealthSource offers information about abdominal aortic aneurysms

FDA approves St. Jude Medical's Unify CRT-D and Fortify ICD devices

Pfizer to acquire terguride from Ergonex Pharma GmbH for treatment of PAH

Boston Scientific receives CE Mark approval for TAXUS Element Paclitaxel-Eluting Coronary Stent System

FDA approves Evia pacemaker for distribution in the U.S.

Nurses give evidence of the horrifying day in Dr. Jayant Patel’s surgery

More for mental health and first nurse led clinic

GTC Biotherapeutics reports lower total net loss of $7.7M for first-quarter 2010

Carrot Medical, MAVIG execute global marketing and sales channel partnership agreement

Clinical Data expands PGxHealth's FAMILION tests to include two new tests to diagnose heart diseases

Spectranetics to demonstrate new Laser Lead Extraction Simulation system at Heart Rhythm 2010

Merck hosts R&D and Business Briefing

Sanford-Burnham Scientific Symposium provides wealth of information on microRNAs, RNAi

Drug-releasing stents do not result in fewer deaths or subsequent heart attacks after angioplasty

Genetic tests represent future of cancer care for women

Wheat aleurone contains high levels of potentially healthpromoting compounds

Mutation causing light chain amyloidosis identified

Gamma Knife stereotactic radiosurgery safe for treating children with arteriovenous malformations: Study

Periodontal disease treatment reduces blood sugar levels in Type 2 diabetes patients

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Heart Disease News and Research

Latest Heart Disease News and Research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Newsletters you may be interested in